한글목차

수의용 생물제제 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 136억 1,000만 달러에서 2026년에는 146억 1,000만 달러로, CAGR 7.3%로 확대가 전망되고 있습니다. 지난 수년간의 성장세는 가축질병의 확산, 반려동물 증가, 백신 개발의 발전, 수의학 연구에 대한 정부 자금 증가, 수의학 인프라의 확충 등이 주요 요인으로 꼽히고 있습니다.

수의용 생물제제 시장 규모는 향후 수년간 견고한 성장이 전망됩니다. 2030년에는 200억 3,000만 달러에 달하며, CAGR은 8.2%에 달할 전망입니다. 예측 기간의 성장 요인으로는 생물제제 기술 발전, 동물 정밀의료 도입 확대, 전 세계 반려동물 사육률 증가, 인수공통전염병에 대한 인식 개선, 수의 진단 시장의 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 예방적 동물의료에 대한 관심 증가, 신속 진단 솔루션의 보급 확대, 반려동물용 생물제제의 확대, 수의학에서 면역조절제의 통합, 가축 질병 관리 솔루션에 대한 수요 증가 등을 들 수 있습니다.

향후 수년간 반려동물 사육 증가가 수의용 생물제제 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 양육은 보호시설이나 구조단체 등에서 가축화된 동물을 인수하여 영구적이고 사랑스러운 가정을 제공하는 책임을 지는 것을 의미합니다. 동물복지에 대한 인식이 높아짐에 따라 보호동물을 기르는 것의 장점을 인식하는 사람들이 늘어나면서 반려동물을 구입하는 것보다 기르는 것을 선택하는 경향이 강해지면서 반려동물 사육이 증가하는 추세입니다. 수의용 생물제제는 반려동물의 다양한 감염 예방, 면역력 제공, 인수공통전염병 통제, 수명 및 삶의 질 향상, 수의학 비용 절감, 생식 건강 증진, 그리고 더 나은 맞춤형 치료 옵션의 실현에 기여합니다. 예를 들어 2025년 3월 미국 비영리단체 '미국 반려동물 제품 협회'가 발표한 자료에 따르면 반려동물을 한 마리 이상 기르는 미국 가정은 9,400만 가구로 2023년 8,200만 가구에서 증가했습니다. 이러한 반려동물 양육률 증가가 수의용 생물제제 시장의 성장에 기여하고 있습니다.

수의용 생물제제 시장의 주요 기업은 동물의 건강 증진과 질병 예방을 위한 백신과 같은 혁신적인 생물제제 개발에 주력하고 있습니다. 백신은 면역체계가 특정 병원체를 인식하고 공격하도록 하는 물질로, 획득면역을 제공하여 감염병을 예방하는 데 기여합니다. 예를 들어 2024년 8월, 미국에 본사를 둔 세계 동물 건강 기업 머크 동물 건강(Merck Animal Health)는 조류 메타뉴모바이러스(aMPV) B형에 대한 실험용 자가백신을 발표하여 미국 농무부(USDA)로부터 제조 및 판매 승인을 받았습니다. 캠브리지 테크놀러지스(Cambridge Technologies)와의 제휴를 통해 개발된 이 백신은 2023년 말 이후 가금류에 심각한 호흡기 질환을 일으켜 막대한 경제적 손실을 초래하는 aMPV B형에 대한 대응을 목표로 하고 있습니다. 미네소타주의 최첨단 시설에서 생산되는 이 백신은 접종 후 조직 반응을 완화하도록 설계된 유수분 에멀전 제형을 채택하고 있으며, 지금까지 시판 허가된 백신이 없었던 시장의 중요한 공백을 메울 수 있는 백신입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Veterinary biologics encompass biological products obtained from living organisms such as viruses, bacteria, or other microorganisms. These specialized products in veterinary medicine serve to prevent, diagnose, or treat diseases in animals.

Key products falling under veterinary biologics include vaccines, diagnostic kits, immunomodulators, antiserums, antibodies, and related items. Vaccines, for instance, are formulated to trigger the immune system's response and offer protection against specific animal diseases. They address various ailments such as bluetongue, foot and mouth disease, brucellosis, tuberculosis, and others. These products are distributed through multiple channels, including veterinary hospitals and clinics, for diverse applications involving both production and companion animals.

Tariffs have impacted the veterinary biologics market by increasing the cost of imported vaccines, diagnostic kits, and immunomodulators, leading to supply chain disruptions in regions such as North America and Europe. Production animal biologics and high-value companion animal products are the most affected segments. While tariffs have raised costs, they have also encouraged local manufacturing and innovation in biologics production, helping regional companies expand capabilities and reduce dependency on imports.

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides veterinary biologics market statistics, including veterinary biologics industry global market size, regional shares, competitors with a veterinary biologics market share, detailed veterinary biologics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. This veterinary biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biologics market size has grown strongly in recent years. It will grow from $13.61 billion in 2025 to $14.61 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to growing prevalence of livestock diseases, rise in companion animal population, advancements in vaccine development, increased government funding for veterinary research, expansion of veterinary healthcare infrastructure.

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $20.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to technological advancements in biologics, increasing adoption of precision medicine in animals, rise in global pet ownership, growing awareness about zoonotic diseases, expansion of veterinary diagnostics market. Major trends in the forecast period include increased focus on preventive animal healthcare, growing adoption of rapid diagnostic solutions, expansion of companion animal biologics, integration of immunomodulators in veterinary treatments, rising demand for livestock disease management solutions.

The growing adoption of pets is expected to drive the growth of the veterinary biologics market in the coming years. Pet adoption involves taking responsibility for a domesticated animal, often from a shelter or rescue organization, and providing it with a permanent and caring home. The adoption of pets is increasing due to greater awareness of animal welfare, as more individuals recognize the advantages of adopting rescued animals and increasingly choose adoption over purchasing pets. Veterinary biologics help prevent a wide range of infectious diseases in pets, provide immunity, control zoonotic diseases, improve lifespan and quality of life, reduce veterinary healthcare costs, enhance reproductive health, and enable more targeted and customized treatment options. For example, in March 2025, the American Pet Products Association, a US-based non-profit organization, reported that 94 million US households owned at least one pet, compared with 82 million households in 2023. Therefore, the rising adoption of pets is contributing to the growth of the veterinary biologics market.

Leading companies in the veterinary biologics market are concentrating on the development of innovative biologics, such as vaccines, to improve animal health and prevent diseases. A vaccine is a substance that triggers the immune system to recognize and combat specific pathogens, helping to prevent infectious diseases by providing acquired immunity. For example, in August 2024, Merck Animal Health, a global animal health company based in the U.S., launched an experimental autogenous vaccine targeting avian metapneumovirus (aMPV) type B, which received approval from the U.S. Department of Agriculture (USDA) for manufacturing and sale. Created in partnership with Cambridge Technologies, this vaccine aims to address the serious respiratory problems caused by aMPV type B in poultry, which have resulted in significant economic losses since late 2023. Manufactured at a state-of-the-art facility in Minnesota, the vaccine uses an oil and water emulsion formulation designed to reduce post-vaccination tissue reactions, filling a crucial gap in the market as there were previously no commercially licensed vaccines available.

In January 2024, Ceva Sante Animale, a pharmaceutical company based in France, acquired Scout Bio for an undisclosed amount. This acquisition enhances Ceva's biotechnology capabilities and speeds up its innovation in pet therapeutics, particularly targeting advanced treatments for chronic diseases. This strategic move responds to the growing demand for better health solutions among pet owners. Scout Bio is a biotechnology company located in the U.S. that specializes in providing essential data for the development of effective veterinary biologics, including vaccines and diagnostics.

Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums

North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biologics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Vaccines; Diagnostic Kits; Immunomodulators; Antiserums And Antibodies; Other Products
• 2) By Disease Type: Bluetongue; Foot And Mouth Disease; Brucellosis And Tuberculosis; Other Disease Types
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Other Distribution Channels
• 4) By Application: Production Animal; Companion Animal
• Subsegments:
• 1) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; DNA Vaccines
• 2) By Diagnostic Kits: Rapid Tests; Elisa Kits; Pcr-Based Diagnostic Kits
• 3) By Immunomodulators: Cytokines; Adjuvants; Immunostimulants
• 4) By Antiserums And Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Hyperimmune Serums
• 5) By Other Products: Probiotics; Prebiotics; Growth Factors; Toxoids
• Companies Mentioned: Zoetis Inc.; Merck Animal Health Inc.; Boehringer Ingelheim Animal Health Inc.; Elanco Animal Health; IDEXX Laboratories Inc.; Virbac SA; Phibro Animal Health Corporation; Abaxis Inc.; Bimeda Biologicals; Ceva Sante Animale S.A.; Heska Corporation; Colorado Serum Company; Hester Biosciences Limited; INDICAL Bioscience GmbH; Intervet Inc.; Hebei Veyong Animal Pharmaceutical Co. Ltd.; Biomet Biologics LLC; CytoDyn Veterinary Medicine LLC; KM Biologics; HIPRA; Indian Immunologicals Ltd.; Vetoquinol; Beijing SVA Vaccines Serums
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Veterinary Biologics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Veterinary Biologics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Veterinary Biologics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Veterinary Biologics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Increased Focus On Preventive Animal Healthcare
  • 4.2.2 Growing Adoption Of Rapid Diagnostic Solutions
  • 4.2.3 Expansion Of Companion Animal Biologics
  • 4.2.4 Integration Of Immunomodulators In Veterinary Treatments
  • 4.2.5 Rising Demand For Livestock Disease Management Solutions

5. Veterinary Biologics Market Analysis Of End Use Industries

• 5.1 Veterinary Hospitals
• 5.2 Veterinary Clinics
• 5.3 Livestock Farms
• 5.4 Research & Diagnostic Laboratories
• 5.5 Animal Health Organizations

6. Veterinary Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Veterinary Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Veterinary Biologics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Veterinary Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Veterinary Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Biologics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Biologics Market Segmentation

• 9.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
• 9.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types
• 9.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
• 9.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Production Animal, Companion Animal
• 9.5. Global Veterinary Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
• 9.6. Global Veterinary Biologics Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
• 9.7. Global Veterinary Biologics Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cytokines, Adjuvants, Immunostimulants
• 9.8. Global Veterinary Biologics Market, Sub-Segmentation Of Antiserums And Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
• 9.9. Global Veterinary Biologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Probiotics, Prebiotics, Growth Factors, Toxoids

10. Veterinary Biologics Market Regional And Country Analysis

• 10.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Biologics Market

• 11.1. Asia-Pacific Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Biologics Market

• 12.1. China Veterinary Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Biologics Market

• 13.1. India Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Biologics Market

• 14.1. Japan Veterinary Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Biologics Market

• 15.1. Australia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Biologics Market

• 16.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Biologics Market

• 17.1. South Korea Veterinary Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Biologics Market

• 18.1. Taiwan Veterinary Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Biologics Market

• 19.1. South East Asia Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Biologics Market

• 20.1. Western Europe Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Biologics Market

• 21.1. UK Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Biologics Market

• 22.1. Germany Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Biologics Market

• 23.1. France Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Biologics Market

• 24.1. Italy Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Biologics Market

• 25.1. Spain Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Biologics Market

• 26.1. Eastern Europe Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Biologics Market

• 27.1. Russia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Biologics Market

• 28.1. North America Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Biologics Market

• 29.1. USA Veterinary Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Biologics Market

• 30.1. Canada Veterinary Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Biologics Market

• 31.1. South America Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Biologics Market

• 32.1. Brazil Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Biologics Market

• 33.1. Middle East Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Biologics Market

• 34.1. Africa Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Biologics Market Regulatory and Investment Landscape

36. Veterinary Biologics Market Competitive Landscape And Company Profiles

• 36.1. Veterinary Biologics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Veterinary Biologics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Veterinary Biologics Market Company Profiles
  • 36.3.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Boehringer Ingelheim Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Biologics Market Other Major And Innovative Companies

• Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA

38. Global Veterinary Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Biologics Market

40. Veterinary Biologics Market High Potential Countries, Segments and Strategies

• 40.1 Veterinary Biologics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Veterinary Biologics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Veterinary Biologics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer